NAYACURE THERAPEUTICS LTD has a total of 11 patent applications. Its first patent ever was published in 2011. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Israel. Its main competitors in its focus markets medical technology, pharmaceuticals and basic materials chemistry are BIOMED PROTECT LLC, TECBOD (XIAMEN) BIOTECHNOLOGY CO LTD and GUANGDONG CAR HOUSE IND DEVELOPMENT HOLDINGS CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Israel | 2 | |
#4 | United States | 2 | |
#5 | China | 1 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Pharmaceuticals | |
#3 | Basic materials chemistry |
# | Technology | |
---|---|---|
#1 | Object sterilising | |
#2 | Medical preparations | |
#3 | Preservation of human bodies | |
#4 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Cohen Shahar | 9 |
Publication | Filing date | Title |
---|---|---|
CN107427535A | Blood clot through modification | |
US2015030569A1 | Methods for inducing immune tolerance to organ transplants | |
IL221238D0 | Pharmaceutical compositions consisting essentially of a stem cell extract , collagen, elastin, hyaluronic acid, fibronectin and laminin | |
EP2533859A1 | Pharmaceutical compositions for the treatment and prevention of cancer |